GeoVax Reports Robust Progress in COVID-19 Vaccine and Cancer Therapy Development
GeoVax Labs highlights significant advancements in its COVID-19 vaccine platform and oncology therapies, securing a major BARDA contract and progressing multiple clinical trials aimed at addressing critical medical needs in immunocompromised populations and cancer treatment.
Read the full story